Isabella Manni

Istituti di Ricovero e Cura a Carattere Scientifico — Italy

Medicine · Health Sciences

29h-index3.2kcitations113works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(22), RNA Research and Splicing(13), Pancreatic and Hepatic Oncology Research(11), MicroRNA in disease regulation(10), Ubiquitin and proteasome pathways(10)

Publications113 total

α-ketoglutarate/succinate ratio imbalance impairs thymine DNA glycosylase function and base excision repair process increasing susceptibility to pancreatic cancer
Cell Death and Disease·2026Open Access
Dysregulated MicroRNAs in Urinary Non-Muscle-Invasive Bladder Cancer: From Molecular Characterization to Clinical Applicability
Cancers·2025Open Access
Estrogen rescues muscle regeneration impaired by DUX4 in a humanized xenograft mouse model
Cell Death and Disease·2025· 2 citedOpen Access
Inactivation of HIPK2 attenuates KRASG12D activity and prevents pancreatic tumorigenesis
Journal of Experimental & Clinical Cancer Research·2024Open Access
The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers
Journal of Experimental & Clinical Cancer Research·2024· 7 citedOpen Access
Bcl-2 family inhibitors sensitize human cancer models to therapy
Cell Death and Disease·2023· 27 citedOpen Access
AATF/Che-1 RNA polymerase II binding protein overexpression reduces the anti-tumor NK-cell cytotoxicity through activating receptors modulation
Frontiers in Immunology·2023Open Access
Supplementary Figures 2 - 3 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Supplementary Table 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Supplementary Figure 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Data from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Data from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Supplementary Figures 2 - 3 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Supplementary Figure 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Supplementary Figure Legends from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Supplementary Table 1 from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Supplementary Figure Legends from Dual Promoter Usage as Regulatory Mechanism of let-7c Expression in Leukemic and Solid Tumors
2023Open Access
Data from Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS–Dependent Pancreatic Ductal Adenocarcinoma
2023Open Access
Supplementary Data from Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
2023Open Access
Data from Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem–Like Cells and Reduces Metastases through Effects on Lipid Anabolism
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Giulia Piaggio(39), Ada Sacchi(12), Aymone Gurtner(11), Roberto Mantovani(6), Luisa de Latouliere(6), Silvia Soddu(5), Simona Artuso(5), Andrea Farina(4), Carlo Gaetano(4), Filippo Galli(4), Alberto Signore(4), Donatella Del Bufalo(4), Maurizio C. Capogrossi(3), Paola Fuschi(3), Simonetta Buglioni(3), Carla Azzurra Amoreo(3), Stefano Menini(3), Carla Iacobini(3), Paola Cappello(3), Francesco Novelli(3)